Allergy Therapeutics PLC Notice of Interim Results (9163Y)
09 March 2017 - 6:01PM
UK Regulatory
TIDMAGY
RNS Number : 9163Y
Allergy Therapeutics PLC
09 March 2017
Allergy Therapeutics plc
("Allergy Therapeutics" or the "Group")
Notice of Interim Results
9 March 2017 Allergy Therapeutics (AIM:AGY), the fully
integrated specialty pharmaceutical group specialising in allergy
vaccines, will issue its interim results for the six months ended
31 December 2016 on Wednesday 29 March 2017.
Manuel Llobet, Chief Executive Officer, and Nick Wykeman,
Finance Director, will hold a presentation and conference call for
analysts on the day of results at 9:00am at Panmure Gordon, One New
Change, London, EC4M 9AF.
Please contact Consilium Strategic Communications for further
details.
- ENDS -
For further information, please contact:
Allergy Therapeutics
+44 (0) 1903 845 820
Manuel Llobet, Chief Executive Officer
Nick Wykeman, Finance Director
Panmure Gordon
+44 (0) 20 7886 2500
Freddy Crossley / Duncan Monteith, Corporate Finance
Tom Salvesen, Corporate Broking
Consilium Strategic Communications
+44 20 3709 5700
Mary-Jane Elliott / Ivar Milligan
allergytherapeutics@consilium-comms.com
Note to editors:
About Allergy Therapeutics
Allergy Therapeutics is an international specialty
pharmaceutical group focussed on the treatment and diagnosis of
allergic disorders including immunotherapy vaccines that cure
disease. The Group sells proprietary products and third party
products from its subsidiaries in nine major European countries and
via distribution agreements in an additional ten countries.
Formed in 1999 out of Smith Kline Beecham, Allergy Therapeutics
is headquartered in Worthing, UK with MHRA-approved manufacturing
facilities. The Group employs c.495 employees and is listed on the
London Stock Exchange (AIM:AGY). For more information, please see
www.allergytherapeutics.com.
This information is provided by RNS
The company news service from the London Stock Exchange
END
NORQVLFBDXFZBBE
(END) Dow Jones Newswires
March 09, 2017 02:01 ET (07:01 GMT)
Allergy Therapeutics (LSE:AGY)
Historical Stock Chart
From Apr 2024 to May 2024
Allergy Therapeutics (LSE:AGY)
Historical Stock Chart
From May 2023 to May 2024